Cargando…

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice

The repetitive applications of vaccine boosters have been brought up in face of continuous emergence of SARS-CoV-2 variants with neutralization escape mutations, but their protective efficacy and potential adverse effects remain largely unknown. Here, we compared the humoral and cellular immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Feng-Xia, Wu, Rui-Xin, Shen, Mei-Ying, Huang, Jing-Jing, Li, Ting-Ting, Hu, Chao, Luo, Fei-Yang, Song, Shu-Yi, Mu, Song, Hao, Ya-Nan, Han, Xiao-Jian, Wang, Ying-Ming, Li, Luo, Li, Sheng-Long, Chen, Qian, Wang, Wang, Jin, Ai-Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625849/ https://www.ncbi.nlm.nih.gov/pubmed/36338436 http://dx.doi.org/10.1016/j.isci.2022.105479

Ejemplares similares

Impaired Humoral Immunity Identified in Inactivated SARS-CoV-2 Vaccine Recipients without Anti-Spike RBD Antibodies
por: Sun, Ting, et al.
Publicado: (2023)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022)

An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
por: Zhang, Haili, et al.
Publicado: (2022)

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
por: Cao, Yunlong, et al.
Publicado: (2022)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
por: Qiao, Yidan, et al.
Publicado: (2022)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
por: Yong, Xiaolan, et al.
Publicado: (2023)

Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling
por: Ai, Jingwen, et al.
Publicado: (2022)

A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains
por: Gao, Fengxia, et al.
Publicado: (2021)

Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses
por: Yang, Songhao, et al.
Publicado: (2023)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

Effects of sodium fluoride on blood cellular and humoral immunity in mice
por: Guo, Hongrui, et al.
Publicado: (2017)

An entomopathogenic fungus exploits its host humoral antibacterial immunity to minimize bacterial competition in the hemolymph
por: Wang, Jia-Lin, et al.
Publicado: (2023)

BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2022)

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
por: Du, Lanying, et al.
Publicado: (2008)

Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors
por: Mohamed, Kauzar Mohamed, et al.
Publicado: (2023)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
por: Hyun, Hakjun, et al.
Publicado: (2023)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer
por: Wang, Xueyan, et al.
Publicado: (2022)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
por: Dalla Gasperina, Daniela, et al.
Publicado: (2023)

In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms
por: Ayers, Emily, et al.
Publicado: (2023)

Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
por: Yang, Lu M., et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice
por: An, Huan-Huan, et al.
Publicado: (2023)

Simultaneous enhancement of cellular and humoral immunity by the high salt formulation of Al(OH)(3) adjuvant
por: Luo, Min, et al.
Publicado: (2017)

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern
por: Ai, Jingwen, et al.
Publicado: (2021)

A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
por: Liu, Xuejie, et al.
Publicado: (2023)

The correlation between possible RBD and cognitive function in Parkinson's disease patients in China
por: Yan, Ya‐yun, et al.
Publicado: (2019)

A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding
por: Long, Yingyi, et al.
Publicado: (2021)

Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients
por: De Cagna, Maria Rosaria, et al.
Publicado: (2023)

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
por: Nishikubo, Masashi, et al.
Publicado: (2023)

Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody
por: Meng, Xianmin, et al.
Publicado: (2021)

Chloroplast RNA-Binding Protein RBD1 Promotes Chilling Tolerance through 23S rRNA Processing in Arabidopsis
por: Wang, Shuai, et al.
Publicado: (2016)

Pneumoconiosis: current status and future prospects
por: Qi, Xian-Mei, et al.
Publicado: (2021)

Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD
por: Hu, Yang, et al.
Publicado: (2015)

Multi-omics study of silicosis reveals the potential therapeutic targets PGD(2) and TXA(2)
por: Pang, Junling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bofp847jfaucpvd9s98eilq93t